8359098

Source:http://linkedlifedata.com/resource/pubmed/id/8359098

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011860, umls-concept:C0017628, umls-concept:C0019010, umls-concept:C0025598, umls-concept:C0030705, umls-concept:C0232105, umls-concept:C0311400, umls-concept:C1280500
pubmed:issue	7
pubmed:dateCreated	1993-9-24
pubmed:abstractText	To compare the metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Fructosamine, http://linkedlifedata.com/resource/pubmed/chemical/Glyburide, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Hexosamines, http://linkedlifedata.com/resource/pubmed/chemical/Metformin, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0149-5992
pubmed:author	pubmed-author:ChanJ CJC, pubmed-author:CockramC SCS, pubmed-author:CritchleyJ AJA, pubmed-author:TomlinsonBB, pubmed-author:WaldenR JRJ
pubmed:issnType	Print
pubmed:volume	16
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1035-8
pubmed:dateRevised	2010-3-24
pubmed:meshHeading	pubmed-meshheading:8359098-Biological Markers, pubmed-meshheading:8359098-Blood Glucose, pubmed-meshheading:8359098-Blood Pressure, pubmed-meshheading:8359098-Cardiac Output, pubmed-meshheading:8359098-Cholesterol, pubmed-meshheading:8359098-Cholesterol, HDL, pubmed-meshheading:8359098-Cholesterol, LDL, pubmed-meshheading:8359098-Diabetes Mellitus, Type 2, pubmed-meshheading:8359098-Female, pubmed-meshheading:8359098-Fructosamine, pubmed-meshheading:8359098-Glyburide, pubmed-meshheading:8359098-Heart Rate, pubmed-meshheading:8359098-Hemodynamics, pubmed-meshheading:8359098-Hemoglobin A, Glycosylated, pubmed-meshheading:8359098-Hexosamines, pubmed-meshheading:8359098-Humans, pubmed-meshheading:8359098-Male, pubmed-meshheading:8359098-Metformin, pubmed-meshheading:8359098-Middle Aged, pubmed-meshheading:8359098-Posture, pubmed-meshheading:8359098-Triglycerides, pubmed-meshheading:8359098-Vascular Resistance
pubmed:year	1993
pubmed:articleTitle	Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.
pubmed:affiliation	Department of Clinical Pharmacology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, N.T.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't